Skip to main navigation Skip to search Skip to main content

Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors

  • Sebastian Obrzut
  • , Kevin McCammack
  • , Karam W. Badran
  • , Anthony Balistreri
  • , Evan Ou
  • , Brian J. Nguyen
  • , Carl K. Hoh
  • , Steven C. Rose

Research output: Contribution to journal › Article › peer-review

Abstract

Objective This study assessed the benefit of post-therapy 18F-FDG PET/CT versus CT alone in identifying malignant liver tumor progression following radioembolization with Y-90 microspheres. Methods 24 patients with 44 liver tumors underwent CT imaging pre-radioembolization and PET/CT post-radioembolization. Predictive value of Response Evaluation Criteria in Solid Tumors (RECIST 1.1), The World Health Organization (WHO), mRECIST and European Association for the Study of the Liver (EASL) with PET/CT versus CT alone was assessed. Results Prediction of liver malignancy progression was improved (p < 0.05) for tumors labeled as non-responding based on combined PET/CT with RECIST 1.1, WHO, mRECIST, and EASL criteria compared to assessment without PET. Conclusions The addition of post-therapy PET to routine CT in patients with hepatic tumors undergoing radioembolization may improve identification of non-responding tumors.

Original languageEnglish (US)
Pages (from-to)43-49
Number of pages7
JournalClinical Imaging
Volume42
DOIs
StatePublished - Mar 1 2017
Externally publishedYes

Keywords

  • F FDG Pet
  • Liver
  • Radioembolization
  • Yttrium 90

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors'. Together they form a unique fingerprint.

Cite this